JP Stock MarketDetailed Quotes

4594 BrightPath Biotherapeutics

Watchlist
  • 68
  • +2+3.03%
20min DelayMarket Closed Jul 29 15:00 JST
4.84BMarket Cap-3734P/E (Static)

BrightPath Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BrightPath Biotherapeutics Earnings Date

Currency: JPY

Period

Q4 FY2024 Earnings

May 10, 2024

Revenue(YoY)

5.00K

-90.20%
EPS(YoY)

-3.07

+25.81%
Analyst Rating

No Data

BrightPath Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

No Data

BrightPath Biotherapeutics Earnings Reports

  • BrightPath Biotherapeutics: Confirmation letter

    Jun 21 02:33 ET

  • BrightPath Biotherapeutics: Securities Report - 21st term (April 1, 2023 - March 31, 2024)

    Jun 21 02:32 ET

  • BRIGHTPATH BIOTHERAPEUTICS: (Correction) Partial Corrections to the “Financial Results Summary for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Unconsolidated)”

    May 10 04:30 ET

  • BRIGHTPATH BIOTHERAPEUTICS: Summary of financial results for the fiscal year ending 2024/3 [Japanese GAAP] (unconsolidated)

    May 10 02:00 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg